BOSTON, Mass., April 20, 2023 -- TetraScience, the Scientific Data Cloud company, announced today a partnership with Apprentice.io, provider of one platform to turn molecules into medicine. Driven by customer demand, the partnership will modernize and accelerate manufacturing processes for next generation therapeutics.
“Apprentice is at the forefront of enabling the biopharmaceutical industry to meet the rigorous demands of biologics and cell and gene therapies production," said Alan Millar, Ph.D., VP, Tetra Partner Network. "Our partnership will enable clients to streamline their manufacturing processes, ensuring safety and expediting the delivery of vital life-changing treatments.”
Apprentice's Tempo Manufacturing Cloud platform is the first modern, cloud-native system of its kind built specifically for the life science industry. The platform empowers manufacturers to replace their paper-based processes or legacy on-premise systems with modern, digital technology solutions. Featuring a Manufacturing Execution System (MES), Augmented Work Instructions (AWI), Laboratory Execution System (LES), and Connected Manufacturing Network (CMN), Tempo's multi-package offering is designed to support all stages of drug manufacturing. By enhancing resource planning, quality standards, and real-time data monitoring, Tempo improves operations at the site level by coordinating the materials, equipment, recipes, and personnel needed to plan, execute, test, and release a batch from one shared system. Integrated Augmented Reality (AR), voice recognition, and AI reduce human error and inefficiency. Using CMN, customers can connect their internal and external sites together to view, manage, and accelerate the end-to-end drug production lifecycle.
The Tetra Scientific Data Cloud(™) centralizes experimental and analytical data from any source and engineers it into Tetra Data — a universally adoptable data format that is liquid, actionable and compliant. The rigorous and precise engineering that produces Tetra Data is a fundamental requirement for advanced analytics and ML/AI. By combining Tetra Data, which is FAIR (Findable, Accessible, Interoperable, Reusable) with Apprentice’s capabilities, customers can generate previously unattainable insights and outcomes.
“TetraScience is transforming how customers amplify the impact of their scientific data across the biopharmaceutical value chain,” said Angelo Stracquatanio, CEO of Apprentice. “Our partnership magnifies the unique strengths of two emerging category leaders, allowing us to modernize the complex, regulated processes associated with the production of drugs, biologics and next-generation therapies.”
“Transforming customer outcomes in manufacturing is simply not possible without a collaborative, industry-wide network of leading vendors whose solutions maximize the value of scientific data,” said Patrick Grady, Chairman and CEO of TetraScience. “We welcome Apprentice to the Tetra Partner Network. Their commitment to unrestricted scientific data will help power the next generation of scientific breakthroughs, create foundations for better therapeutics, and thereby solve humanity's greatest challenges.”
About TetraScience
TetraScience is the Scientific Data Cloud company with a mission to accelerate scientific discovery and improve and extend human life. The Tetra Scientific Data Cloud™ is the only open, cloud-native platform purpose-built for science that connects lab instruments, informatics software, and data apps across the biopharma value chain and delivers the foundation of harmonized, actionable scientific data necessary to transform raw data into accelerated and improved scientific outcomes. Through the Tetra Partner Network, market-leading vendors access the power of our cloud to help customers maximize the value of their data. For more information, please visit tetrascience.com.
About Apprentice
Apprentice's disruptive technology helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. The company's Tempo Manufacturing Cloud accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and sharing real-time enterprise-wide visibility. Learn how 15 of the top 20 US pharma companies use Apprentice to accelerate high-quality production of drugs for diseases of all types, from COVID to cancer, at www.apprentice.io.